High Seroprevalence of Human Herpesviruses in HIV-Infected Individuals Attending Primary Healthcare Facilities in Rural South Africa

Seroprevalence data of human herpesviruses (HHVs) are limited for sub-Saharan Africa. These are important to provide an indication of potential burden of HHV-related disease, in particular in human immunodeficiency virus (HIV)-infected individuals who are known to be at increased risk of these conditions in the Western world. In this cross-sectional study among 405 HIV-infected and antiretroviral therapy naïve individuals in rural South Africa the seroprevalence of HHVs was: herpes simplex virus type 1 (HSV-1) (98%), herpes simplex virus type 2 (HSV-2) (87%), varicella zoster virus (VZV) (89%), and 100% for both Epstein-Barr virus (EBV) and cytomegalovirus (CMV). Independent factors associated with VZV seropositivity were low educational status and having children. Lack of in-house access to drinking water was independently associated with positive HSV-1 serostatus, whereas Shangaan ethnicity was associated with HSV-2 seropositivity. Increasing age was associated with higher IgG titres to both EBV and CMV, whereas CD4 cell count was negatively associated with EBV and CMV IgG titres. Moreover, IgG titres of HSV-1 and 2, VZV and CMV, and CMV and EBV were positively correlated. The high HHV seroprevalence emphasises the importance of awareness of these viral infections in HIV-infected individuals in South Africa.

[1]  O. Opare-Sem,et al.  Prevalence of persistent and latent viruses in untreated patients infected with HIV‐1 from Ghana, West Africa , 2009, Journal of medical virology.

[2]  N. Hens,et al.  Serology indicates cytomegalovirus infection is associated with varicella‐zoster virus reactivation , 2014, Journal of medical virology.

[3]  S. Chakrabarti,et al.  Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario , 2010, Virology Journal.

[4]  Jennifer S. Smith,et al.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. , 2002, The Journal of infectious diseases.

[5]  C. Masuet-Aumatell,et al.  Seroprevalence of varicella‐zoster virus infection in children from Cochabamba: tropical or temperate pattern? , 2012, Tropical medicine & international health : TM & IH.

[6]  J. Brooks,et al.  Prevalence and Risk Factors Associated With Herpes Simplex Virus-2 Infection in a Contemporary Cohort of HIV-Infected Persons in the United States , 2012, Sexually transmitted diseases.

[7]  J. Baeten,et al.  Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study , 2009, PloS one.

[8]  B. Stilwell,et al.  Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .

[9]  B. Wahrén,et al.  Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[10]  R. Nichols,et al.  Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity , 2011, Epidemics.

[11]  R. Hayes,et al.  The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations , 2001, AIDS.

[12]  I. Mohr,et al.  Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. , 2010, Cell host & microbe.

[13]  U. Schaad,et al.  Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity , 2001, The Pediatric infectious disease journal.

[14]  U. Gyllensten,et al.  A fas gene polymorphism influences herpes simplex virus type 2 infection in South African women , 2010, Journal of medical virology.

[15]  B. Stray-Pedersen,et al.  Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania. , 2011, East African journal of public health.

[16]  A. Wald Herpes simplex virus type 2 transmission: risk factors and virus shedding. , 2004, Herpes : the journal of the IHMF.

[17]  L. Juárez-Figueroa,et al.  Population-based prevalence of antibodies against herpes simplex virus type 2 and socio-demographic characteristics in Mexico. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  E. Kozlova,et al.  Chronic herpesvirus reactivation occurs in aging , 2007, Experimental Gerontology.

[19]  D. Consonni,et al.  Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. , 1997, International journal of epidemiology.

[20]  Jeffrey N. Martin,et al.  Substantial regional differences in human herpesvirus 8 seroprevalence in sub‐Saharan Africa: Insights on the origin of the “Kaposi's sarcoma belt” , 2010, International journal of cancer.

[21]  H. Weiss,et al.  Epidemiology of herpes simplex virus type 2 infection in the developing world. , 2004, Herpes : the journal of the IHMF.

[22]  Neil Pearce,et al.  Effect Measures in Prevalence Studies , 2004, Environmental health perspectives.

[23]  K. Rajewsky,et al.  EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. , 2000, Immunity.

[24]  J. Sinclair Human cytomegalovirus: Latency and reactivation in the myeloid lineage. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[25]  J. Kiecolt-Glaser,et al.  Changes in Epstein-Barr Virus Antibody Titers Associated with Aging , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  J. Goodwin,et al.  Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age , 2012, Journal of medical virology.

[27]  E. Gouws,et al.  HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour , 2001, AIDS.

[28]  Craig S. Miller,et al.  High Prevalence of Multiple Human Herpesviruses in Saliva from Human Immunodeficiency Virus-Infected Persons in the Era of Highly Active Antiretroviral Therapy , 2006, Journal of Clinical Microbiology.

[29]  J. Kempen,et al.  Ocular immune reconstitution inflammatory syndromes , 2008, Current opinion in HIV and AIDS.

[30]  J. Torres,et al.  Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico. , 1999, Archives of medical research.

[31]  E. Sanders,et al.  Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya , 2011, BMC infectious diseases.

[32]  S. Esser,et al.  Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis , 2013, BMC Infectious Diseases.

[33]  A. Oxenius,et al.  Impact of antigen specificity on CD4+ T cell activation in chronic HIV-1 infection , 2013, BMC Infectious Diseases.

[34]  A. Trkola,et al.  HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses , 2010, EMBO molecular medicine.

[35]  S. Staszewski,et al.  Prevalence- and Gender-Specific Immune Response to Opportunistic Infections in HIV-Infected Patients in Lesotho , 2010, Sexually transmitted diseases.

[36]  A. Flahault,et al.  Micro and macro population effects in disease transmission: the case of varicella , 2009, Epidemiology and Infection.

[37]  A. Molesworth,et al.  Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa , 2012, Tropical medicine & international health : TM & IH.

[38]  A. Adjei,et al.  Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa , 2008, BMC infectious diseases.

[39]  P. Klenerman,et al.  Viral coinfections among African children infected with human immunodeficiency virus type 1. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.